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ABSTRACT
Research in the Department of Pharmacology started to focus intensively on fetal circulation in the 60s. Results of experiments 
contributed to clarification of the conversion of fetal circulation type to the adult type: the mechanism of the ductus arteriosus closure, 
examination of fetal and neonatal pulmonary vessel responses. In the early 80s, increased attention was dedicated to fetal vascular 
endothelium, later on to vascular reactivity in relation to the endothelium in adult animals. We developed original models of vascular 
endothelial damage using the perfusion method (repeated vasoconstrictive stimuli, deendothelization by air bubbles). We developed 
a new technique for in vitro endothelial loss quantification on Millipore filters. Under in vitro conditions, the protective effects of 
sulodexide and pentoxifylline on vascular endothelium were evaluated. In recent years were studied protective effects of selected 
substances in vivo in models of endothelial damage (e.g. stress, toxic tissue damage, diabetes mellitus, hypertension). The role of potas-
sium channels in the hypertension model was studied in cooperation with the Czech Academy of Sciences. Assessment of vascular 
reactivity in the diabetic model was significantly improved by computer. In addition to experimental work, the department is solving 
problems of clinical pharmacology – especially drug risk evaluation (non-steroidal anti-inflammatory drugs). Recently, we have dealt 
with pharmacoepidemiological studies in geriatric patients and with cardiovascular risk of NSAIDs in relation to pharmacotherapy. The 
results of these studies may be an impulse for targeted problem solving in our experiments. 
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this closure. The role of prostaglandins, kinins and other 
vasoactive substances, as well as the myogenic activity of 
ductus arteriosus, was studied in other research work of 
the department (Kriška & Kovalčík, 1973; Smieško et al., 
1978). With time, the topic of fetal vessels logically con-
tinued in the study of pulmonary and umbilical vessels 
reactivity (Kristová et al., 1986), which in the perinatal 
period contributes crucially to the transformation of fetal 
circulation to the adult type. In addition to the study of 
effects of vasoactive substances (biogenic amines, kinins, 
prostaglandins) and medicaments (ambroxol, glucocor-
ticoids) on pulmonary vessels, research was extended 
t o  e v a l u a t e  e f f e c t s  o f  e n d o t h e l i n  o n  t h e  p u l m o n a r y  
circulation of fetal sheep (Cassin et al., 1991). Parallel 
with the research of vessel reactivity in ontogenesis, our 
department also examined the effects of hormones on 
vascular responses. In the early 80s, increased attention 
Introduction
Research in cardiovascular pharmacology has a long 
tradition in our department and in the past decade it has 
undergone significant changes. In the 60s, we focused on 
fetal blood vessels, and particularly on the role of fetal 
shunts, such as the ductus arteriosus, in the conversion 
from a fetal to an adult type of circulation. Research 
achievements of Kovalčík (1963) contributed significantly 
to the clarification of the mechanism of ductus arteriosus 
closure and especially of the crucial role of oxygen in 
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was given to fetal vascular endothelium, starting from the 
morphological aspect and later on to the vessel response 
(Babál et al., 1987). Subsequently, we focused our study 
on vascular reactivity in relation to the endothelium 
in adult animals (Kriška et al., 1989). We evaluated the 
impact of factors increasing the risk of endothelium dam-
age – as the duration of vessel storage and application of 
vasoconstrictive substances (Kristová et al., 1993). Results 
of these experiments led to their targeted use in further 
experiments. We designed in vitro models of vascular 
endothelial damage using the perfusion method – method 
of repeated vasoconstrictive stimuli induced by norepi-
nephrine, vascular deendothelization by air bubbles, 
and endothelial damage by perfusion with activated 
polymorphonuclear leukocytes. Under conditions of the 
perfusion method, we developed an original technique 
to quantify the endothelial loss on Millipore filters after 
the use of deendothelization stimuli (Babál et al., 1992).
After verification of experimental models of endothelial 
damage in vitro, we started to evaluate effects of different 
drugs and substances on the endothelium. First we inves-
tigated effects of nonsteroidal anti-inflammatory drugs, 
which by inhibiting the synthesis of vasodilator prosta-
glandins potentiated the vasoconstrictive responses of 
femoral and renal arteries (Kristová et al., 2000; 2002).
Under conditions in vitro, the potential protective 
effect of sulodexide and pentoxifylline on vascular endo-
thelium was evaluated (Kristová et al., 1995; 2000; Babál 
et al., 1996). In the last years, we studied endothelium-
protective effects of selected substances in experimental 
models of endothelial damage in vivo; particularly in the 
stress model, the model of toxic tissue damage by carbon 
tetrachloride and in the diabetic model (Kristová et al., 
2006; 2008; Babál et al., 2006). Mechanism of vascular 
reactivity in relation to potassium channels in hyperten-
sive animals were revealed in experiments carried out in 
cooperation with the Institute of Physiology, Academy 
of Sciences, Czech Republic (Líšková et al., 2007). The 
results obtained by traditional methods of vascular 
response evaluation often fail to show an authentic view 
on contractile responses (phasic and tonic component). 
Digital recording of contractile responses using modern 
software enables mathematical analysis of perfused vessel 
reactivity. We obtained original results, which quantify a 
wide set of parameters not investigated so far (Dedík et 
al., 2003; Vojtko et al., 2010).
In cooperation with clinical institutes, our department 
has been dealing for a long time with some problems of 
clinical pharmacology – mostly based on experimental 
results. As the most serious problem we consider drug risk 
evaluation, concerning particularly analgesics. Adverse 
effects of nonsteroidal anti-inflammatory drugs in high-
risk patients were evaluated in cooperation with National 
Institute of Rheumatic Diseases. In collaboration with 
clinical departments, problems of pharmacotherapy of 
peripheral circulation disorders were studied (Kriška et 
al., 2002; Rajec et al., 2007).
Recently, the staff of our department has focused on 
the pharmacoepidemiological studies in geriatric patients 
(Wawruch et al., 2008) and on the cardiovascular risk 
of NSAIDs in relation to pharmacotherapy (Varga et al., 
2010). The results of these studies may be an impulse for 
targeted problem solving, especially in clarifying serious 
cardiovascular disorders resulting from drug interactions.
Selected results from the recent period
A. Experimental part
Evaluation of endothelium-protective eﬀ  ects of sulodexide 
on experimental model of diabetes mellitus
Diabetes mellitus (DM) is generally associated with 
many cardiovascular complications accompanied with 
development of endothelial dysfunction or damage. 
T h e r e f o r e ,  th e  us a g e  o f  s o m e  dru g s ,  as  s ta tins ,  A C E  
inhibitors, pentoxifylline, may have a protective effect on 
the endothelium. Based on our previous experience with 
sulodexide (glycosaminoglycan composed of heparin-like 
and dermatan fractions), we decided to evaluate its endo-
thelium-protective effects in the model of streptozotocin-
induced DM. We focused mainly on measurement of the 
number of circulating endothelial cells in peripheral 
blood as a morphological marker of endothelial injury and 
on evaluation of acetylcholine-induced relaxations of the 
rat mesenteric artery as a marker of endothelial function.
Table 1. Effect of sulodexide (SLX) on number of circulating endo-
thelial cells in plasma [EC/10μl] in control (C), SLX treated (SLX), dia-
betic (DM) and diabetic rats treated with SLX (DM+SLX) in 10-week 
diabetes mellitus.
C SLX DM DM+SLX
1.88 
(0.75; 2.25)
2.38 
(1.75; 3.00)
3.88 
(3.25; 5.75)****++
2.25 
(1.75; 3.50)#
Data are expressed as medians and their 95% confidence intervals, 
****p<0.0001: Control vs. DM, ++p<0.01: SLX vs. DM,  #p<0.02: DM vs. DM+SLX.
0
8765
20
40
60
80
100
%
 
o
f
 
c
o
n
c
e
n
t
r
a
t
i
o
n
Acetylcholine (-log mol/l)
*
*
*
#
#
#
Control
SLX
DM
DM + SLX
Figure 1. Eff  ect of sulodexide treatment (SLX) on acetylcholine-
induced relaxation of mesenteric artery in rats with 10-week dia-
betes (DM) compared to control and diabetic rats treated with 
sulodexide (DM+SLX). 
*p<0.05: Control vs. DM, #p<0.05: DM vs. DM+SLX.42
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Methods
The following groups of animals were used in experiments: 
control (C, saline solution), sulodexide (SLX, 100 UI/kg/
day), DM, induced by administration of streptozotocin 
(STZ in the dose 30 mg/kg/day i.p. over 3 consecutive days), 
DM+SLX. Treatment with sulodexide lasted 10 weeks. 
Isolated vessels were cut into rings for measurement of 
isometric contractions. The number of endothelial cells 
in blood was measured in Bürker´s chamber according 
to a previously described method (Kristová et al., 2006).
Results
Ten weeks of diabetes significantly impaired acetylcho-
line-induced relaxations of isolated mesenteric arteries 
compared to controls (Figure 1). SLX treatment improved 
endothelium-dependent relaxation in mesenteric arteries 
although the control level was not reached. Increased 
endothelemia was found in diabetic animals compared 
to the controls, which is in agreement with results of our 
previous study (Zúrová-Nedelčevová et al., 2006). SLX 
significantly decreased the number of circulating endo-
thelial cells (Table 1). The obtained results demonstrate 
that sulodexide has endothelium protective effects in 
streptozotocin-induced diabetes. The favorable effects 
of SLX in peripheral occlusive arterial disease were con-
firmed in clinical studies (Gaddi et al., 1996).
Eﬀ  ects of L-NNA and indomethacin on vascular tone of femoral 
arteries in Wistar-Kyoto and spontaneously hypertensive rats 
Prevention and treatment of hypertension have been 
intensively studied, but the mechanisms of hypertension 
remain still elusive. Hypertension is the leading risk factor 
of cardiovascular diseases. Cardiac output and peripheral 
resistance regulate blood pressure. Our group focuses on 
the regulation of vascular tone, which determines periph-
eral resistance. There are several relaxing and constrict-
ing factors, mostly produced by the endothelium, which 
control vessel diameter, blood flow and vascular tone. The 
main vasodilating factors produced by the endothelium 
are nitric oxide (NO), endothelium derived hyperpolar-
izing factor (EDHF) and prostaglandins (PGI2, PGE2, 
PGD2). The basic vasoconstrictors include endothelins, 
thromboxane A2 (TXA2) and prostaglandins (PGG2, 
PGH2). Endothelium-derived constricting factor (EDCF) 
is probably a product of cyclooxygenase activity, but this 
factor has not been identified until today. 
Methods
Our experiments are oriented on the effect of endothelium-
derived relaxing (NO) and constricting (EDCF) factors in 
norepinephrine (NE)-induced contraction. Isolated femo-
ral arteries of 6-month-old normotensive Wistar-Kyoto 
rats (WKY) and 6-month-old spontaneously hypertensive 
rats (SHR) were placed in on isometric Mulvany-Halpern 
myograph. Contraction of femoral arteries with intact 
endothelium were induced by cumulative doses of NE 
(10–9–10–5 mol/l). The presence of endothelium was 
tested by acetylcholine application. NE-induced contrac-
tion response curves were constructed under control 
conditions as well as in the presence of the NO synthase 
inhibitor N(ω)-nitro-L-Arginine (L-NNA; 10–4 mol/l) 
and the cyclooxygenase inhibitor indomethacin (IME; 
10–5 mol/l). 
Results
Our results showed that the NE-induced contraction was 
augmented in vessels isolated from hypertensive animals. 
The application of L-NNA increased NE-induced contrac-
tion in WKY (Figure 2), but was almost without effect in 
vessels from SHR. Inhibition of cyclooxygenase markedly 
impaired NE-induced contractions of femoral arteries of 
WKY (Figure 2) and SHR. 
This impairment was more pronounced in arteries 
of SHR. We suggest that one possible mechanism of 
enhanced contractility of vessels during hypertension 
may be explained by the action of endothelium-derived 
constricting factor.
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Figure 2. Reactivity of isolated femoral artery with intact 
endothelium (original records from myograph), Wistar-Kyoto rats. 
Horizontal axis: time in min. Vertical axis: wall tension in mN/mm. 
Ach – acetylcholine, arrows indicate application of initial nore-
pinephrine or acetylcholine dose. 
At the top: norepinephrine-induced contraction. 
In the middle: norepinephrine-induced contraction in the pres-
ence of L-NNA (N(ω)-nitro-L-Arginine).
At the bottom: norepinephrine-induced contraction in the pres-
ence of L-NNA and IME (indomethacin).43
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Contribution of computer-based modeling to 
assessment of vascular reactivity of diabetic rats
Evaluation of contractile responses of perfused vascular 
segments in vitro is traditionally based mainly on deter-
mination of the maximum response – amplitude (pmax) 
and in some cases on the time needed from the start of the 
record to reach this peak (tmax). Such descriptive methods 
of evaluation are related to data extraction from graphic 
records of contractions obtained by analog recorders and 
loaded with subjective inaccuracy of evaluator and a lower 
reproducibility of the acquired data.
Substantial enrichment of the results of our experi-
mental work was provided by the involvement of new 
software, using the measurement card recording the 
contraction response of isolated segments digitally. This 
enabled quantification and evaluation of a wide set of 
contractile response parameters, whose determination 
was not possible by routine descriptive methods. Digital 
recording of the vessel segment responses to series of suc-
cesively increasing doses of norepinephrine was followed 
by computational modeling determining the resulting 
parameter values of the segment reactivity. In comparison 
with analog data extraction, no information gets lost – 
two key parameters measurable by descriptive procedures 
(pmax, tmax) quantify computer methods more rapidly and 
more precisely.
Methods
Computer-based modeling of digital records of contrac-
tions is based on general system theory and uses the analy-
sis of the properties of the system tested through modeling 
output responses (contractions) to defined inputs (single 
doses of norepinephrine). The initial step of this analysis 
is a data-number reduction by standard algorithm, which 
from originally recorded approximately 250 points retains 
30–40 representative points for the course of every 
contractile response. For the next analysis each artery seg-
ment is considered as dynamic system H and computer-
based modeling determines a representative set of model 
parameters, as defined by the system transfer function H(s):
H(s) = G
a0 + a1s + a2s2 + . . . + ansn
1 + b1s + b2s2 + . . . + bmsm ,
where G, a0, .... an, b1, .... bm are the parameters of the 
model, n and m are the highest values of numerator, 
respectively denominator of the polynomial H(s). The 
values of the transfer function as an argument of complex 
variable s, represent the ratio of the output and input of 
system H after the Laplace transformation. The modeling 
procedures used were described by Dedík et al. (2003). 
The final result of modeling is to obtain the representative 
model curves of contractile responses and quantification 
of defined model parameters. These include the most 
important and characteristic ones for the contractile 
response – vascular sensitivity S (determined by the 
parameter G, in our model S = G), mean time of vaso-
constrictor response MTVR and the rate constant of 
relaxation krel.
Sensitivity of the renal artery segment determines the 
ratio of the area under curve of the measured profile of 
contractile response and norepinephrine dose. Mean time 
of vasoconstrictor response represents the time point of 
centroid of this profile. Rate constant of relaxation stands 
for the lowest from the absolute values among the mem-
bers in the denominator of the polynomial H(s) equation. 
The sensitivity S in relation to the effect of norepineph-
rine represents its intensity, MTVR its duration and krel its 
regression (Dedik et al., 2003).
Results
Our results in the model of streptozotocin-induced diabe-
tes in rats were obtained by application of the computer-
based modeling procedures for detailed data extraction. 
On the one hand, values of descriptive parameters pmax 
and tmax did not show statistically significant differences 
in the reactivity of renal artery segments between the 
control and diabetic group. On the other hand, the course 
of the curves showing values of the key parameter S for 
each dose of norepinephrine (range 0.5–10  μg) showed 
distinct differences with statistical significance at the 
dose of 1 μg (Figure 3). 
Evaluation of parameters MTVR (Figure 4A) and krel 
(Figure 4B) for selected doses with the highest sensitivity 
at 0.5 and 1 μg and the model type 1–4 (n = 1, m = 4) 
showed difference between the control and diabetic group, 
but without statistical significance. The model parameter 
S and krel values suggest a slower pressure decrease in the 
vascular segment after reaching the peak value in the dia-
betic group compared to control. Based on these results, 
we expect disturbance of the wall elasticity of the renal 
artery segments tested which may increase vascular rigid-
ity (Vojtko et al., 2010). Such alterations associated with 
diabetic angiopathy have been documented by several 
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Figure 3. Sensitivity of renal artery segments. Comparison 
between control group and diabetic. Values are given as mean 
± SEM, *p<0.05.44
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clinical and experimental studies (Lagaud et al., 2001; 
Sivitz et al., 2007). Computational modeling as a meth-
odological approach shows a new previously unavailable 
way to precise evaluation of elasticity and other essential 
functional properties of the vessel wall using the perfu-
sion method, which belongs to in vitro methods closest to 
physiological conditions.
The described mathematical modeling of digitally 
recorded contractile responses meets the expectations of 
accuracy and high reproducibility of data extraction, rep-
resenting an improvement of the traditional assessment 
of analog records. It may offer a new view by providing a 
more detailed and exact description of responses to dif-
ferent substances on vessel segments, which seems to be 
a significant progress compared with routine descriptive 
methods. 
B. Clinical part
Cardiovascular drugs potentially inappropriate for elderly patients
Persons aged ≥ 65 years are more susceptible to adverse 
drug reactions compared to younger people. Changes in 
drug pharmacokinetics and pharmacodynamics, frequent 
non-compliance, polymorbidity and polypharmacy con-
tribute to a greater frequency of drug-related problems 
(Turnheim, 2003). Higher occurrence of adverse effects 
in el d e r ly pa ti e n ts is associa ted parti cular ly wi th th e  
administration of certain drug. Therefore several lists of 
potentially inappropriate medications for elderly patients 
were published at the end of the 20th and the beginning 
of the 21st century (McLeod et al., 1997; Fick et al., 2003). 
These lists include drugs with increased risk of adverse 
effects if they are administered to patients aged 65 or 
more. Other reasons for including a medicine into such 
lists are high probability of drug-drug interaction and 
lack of information on the efficacy of the drug in elderly 
patients in accordance with the requirements of evidence-
based medicine. The Beers criteria published in 2003 
represent an internationally recognized list of potentially 
inappropriate medications and they reflect current 
knowledge in the field of gerontopharmacology.
Methods
The sample of our study (n=345) was selected from 524 
patients aged ≥65 years hospitalized in a municipal hospi-
tal during the time period of August 1, 2004 to March 31, 
2005. Patients who died during hospitalization and those 
with incomplete documentation were excluded from the 
study. All medications at the time of hospital admission 
were recorded for each patient. Cardiovascular medica-
tions potentially inappropriate for older patients were 
identified using modified Beers criteria published in 2003 
(Fick et al., 2003).
Results
The mean age of the whole group (n=345) was 76.9 ± 7.4 
years. The study population consisted of 206 (59.7%) 
women and 139 (40.3%) men. At the time of hospital 
admission, 65 (18.8%) out of 345 patients were treated 
with at least one potentially inappropriate medication 
(Table 2). The most frequently prescribed potentially inap-
propriate medicine was digoxin at a dose > 0.125 mg/day 
(except when treating atrial arrhythmias), followed by 
ticlopidine and amiodarone. The high use of digoxin at 
doses > 0.125 mg/day may be explained by the frequent 
occurrence of chronic heart failure in the evaluated group 
as well as by remaining prescription habits. Ticlopidine 
was the most frequently prescribed potentially inappro-
priate medication also in the study of Onder et al. (2005). 
The authors explain this finding by unavailability of the 
Table 2. Potentially inappropriate cardiovascular drugs used in treat-
ment of elderly patients. 
Drug Frequency (% of n=345)
digoxin* 44 (12.8)
ticlopidine 28 (8.1)
amiodarone 19 (5.5)
methyldopa 5  (1.4)
doxazosin 3  (0.9)
digoxin in doses > 0.125 mg/day (except when treating atrial arrhythmias)
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Figure 4. Mean time of vasoconstrictor response (A) and the rate constant of relaxation (B) of renal artery segments at norepinephrine 
doses 0.5 and 1.0 μg. C 0.5 – control group, dose 0.5 μg; C 1.0 – control group, dose 1.0 μg; D 0.5 – diabetic group, dose 0.5 μg; D 1.0 – dia-
betic group, dose 1.0 μg. Values are given as mean ± SEM.45
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safer alternative clopidogrel in Italy at the time of their 
analysis (1997–1998). Similarly the prescription limitation 
caused by the high price of clopidogrel contributed to the 
high prevalence of ticlopidine at the time when our study 
was carried out. The situation is changing due to current 
availability of cheaper generic variants of clopidogrel.
Rational attempts to reduce the use of potentially inap-
propriate medications can have a positive impact on the 
healthcare system. Our results underline the importance 
of paying more attention to the topic of pharmacological 
treatment in elderly patients during pre- and post-gradu-
ate education of healthcare professionals.
Use of non-steroidal anti-inﬂ  ammatory drugs and risk of 
cardiovascular adverse eﬀ  ects in hospitalized patients
The group of non-steroidal anti-inflammatory drugs 
(NSAIDs ) is one of the most prescribed drug groups  
worldwide. Several NSAIDs are available over the coun-
ter; they are used by a large number of patients without 
prescription. The widespread use of non-steroidal anti-
inflammatory drugs is caused by the high prevalence of 
diseases causing acute or chronic pain in the popula-
tion. Diseases accompanied by inflammation and fever 
also occur in a substantial number of patients. Adverse 
drug reactions of NSAIDs represent a serious medical 
problem because of the high number of exposed patients. 
C o n t i n u o u s  a n a l y s i s  o f  a n a l g e s i c  u s a g e  i s  n e e d e d  t o  
improve the safety of analgesic therapy. 
Methods
Retrospective data collection from documentation of 
p a t i e n t s  h o s p i t a l i z e d  i n  t h e  d e p a r t m e n t  o f  i n t e r n a l  
medicine of a district hospital; data were analyzed using 
methods of descriptive statistics. 
Results
In our recent pilot study , data obtained from medical 
records of 112 patients receiving NSAIDs during hospi-
talization in the department of internal medicine were 
evaluated with focus on analgesic prescription and risk 
of cardiovascular adverse effects (Varga et al., 2010). The 
mean age was 63.7 years (SD, 15.0), 67% of the patients in 
the study group were women. The most commonly used 
non-steroidal anti-inflammatory drug was metamizol 
(76 patients; 67.9% of the study group). Diclofenac (20; 
17.9%), indomethacin (16; 14.3%) and ketoprofen (14; 
12.5 % ) w ere also used by a high n umber of pa tien ts.  
Preferential inhibitors of COX-2 were administered to 
17 patients (nimesulide – 10; 8.9%; meloxicam – 7; 6.3%). 
Arterial hypertension, chronic heart failure and ischemic 
heart disease were the most frequent diagnoses indicating 
increased risk for development of cardiovascular adverse 
effects of NSAIDs (Table 3). 
Administration of NSAIDs can lead to elevation of 
arterial blood pressure (Chan et al., 2009; White, 2007), 
the greatest risk is present in patients with controlled 
arterial hypertension using ACE inhibitors, angiotensin 
receptor blockers and beta-blockers (White, 2007). In our 
study group, the most frequently used antihypertensive 
drugs were beta-blockers and ACE inhibitors (Figure 5). 
Results of the discussed pilot study need to be con-
firmed in a study with a large number of enrolled patients. 
The possible pathophysiological mechanisms leading 
to cardiovascular toxicity of NSAIDs will be studied in 
animal experiments.
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Table 3. Diagnoses indicating increased risk of CVS adverse effects 
Diagnoses 
Number of 
patients
% of the 
study group
Arterial hypertension 64 57.1%
Chronic heart failure 47 42.0%
Ischemic heart disease 46 41.1%
Diabetes mellitus 33 29.5%
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Figure 5. Drugs used in antihypertensive treatment in study 
group.
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